chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mar 30, 2021- 1st covid vaccine left arm apr 1- april 21 bruising left arm april 16- primary dr visit for bruise left arm april 30- 2nd covid vaccine right arm May 13- primary dr visit for arm pain in vaccine area left arm May 26- primary dr visit for physical- prescribed hormone therapy Jun 1 began taking estrogen/progesterone June 10- chiro visit left arm pain June 16- chiro visit left arm pain June 24- chiro visit left arm pain July 1- primary dr visit arm pain left arm shoulder xray July 8- Ortho visit left arm pain Aug 20- MRI left shoulder- Diagnosis adhesive capsulitis Sept 1- Ortho visit- referral to physical therapy for adhesive capsulitis Sept 2- ongoing 2x weekly physical therapy for left shoulder
Chief Complaint:   SOB, Cough, Fatigue, No Appetite, COVID+  Patient tested positive for COVID-19 on 08/13/21 and had Regeneron infusion on 08/19/21. Patient had recent chest XR indicating left lower lobe infiltrate and was sent by MD for COVID pneumonia. In remission for prostate cancer.
Slight rash on upper back, sore throat one evening and eye bacame very red in the corner
became dizzy, felt faint; began to draw in extremities & make snoring sound; lasted only 20 sec;
Dizziness, Headache & NauseaVomiting Narrative:  Employee received second dose of Moderna vaccine on 08/05/21 at 09:34 and began reporting symptoms of "feeling hot, then dizzy." nausea, headache, and injection site pain. Employee was seen by employee health physician at that time. Vitals as follows at 09:34: temp 96.4 F, resp rate 18, pulse 77, O2 sat 100%, BP 119/79. At 10:24, rechecked BP was 128/87. Employee was sent home, family member picked her up from work. Employee was advised to seek medical attention should the symptoms continue or worsen. No medications were given at that time. No other information provided.
back very sore. Especially my spine; Muscles are very sore; Back are very sore. Especially my spine; Injection site hurts a lot; This case was reported by a consumer via call center representative and described the occurrence of back pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd March 2020, the patient received the 1st dose of Shingrix. In March 2020, less than a week after receiving Shingrix, the patient experienced back pain, muscle pain, pain in spine and injection site pain. On an unknown date, the outcome of the back pain, muscle pain, pain in spine and injection site pain were unknown.   It was unknown if the reporter considered the back pain, muscle pain, pain in spine and injection site pain to be related to Shingrix.  Additional case details were reported as follows: This case was reported by patient for self. The age at vaccination was not reported. A day before time of reporting, the patient received a dose of Shingrix. The patient's back and muscles were very sore, especially spine and also injection site hurts too. The patient asked whether to get the 2nd shot in may.
82YM Admit 3/18/21 to hospital for small bowel obstruction within 1 week of  second vaccine dose. PTA bowel obstruction led to a syncopal episode following use of laxative, and several episodes of vomiting in the days prior . Upon admission Patient was receiving conservative therapy for a partial obstruction when he developed increasing shortness of breath.  The patient was transferred to the ICU for worsening respiratory status and eventually developed significant hypercapnic and hypoxemic respiratory failure requiring intubation.  Neurology was consulted for altered mentation in the setting of respiratory failure. Patient with ascending paralysis. MRI of the head and neck as well as CTA were obtained x2. Patient was ultimately diagnosed with Guillain-Barre, variant and received 5 days of Intravenous Immune Globulin therapy.  Patient's small bowel obstruction resolved and ultimately patient required percutaneous tracheostomy tube and gastrostomy tube placement for prolonged respiratory failure and neurologic compromise.  The patient had uneventful ventilatory requirements and ultimately was performing intermittent spontaneous breathing trials; however, still had episodes of apnea, but improved.  He was tolerating tube feeds at goal with resolution of his small bowel obstruction, which was thought secondary to his Guillain-Barre.  The patient did develop abnormal LFTs which were thought secondary to cholecystitis not requiring operative intervention, with improving LFT findings on antibiotics.  The patient had a nonobstructive cholecystitis.  The patient's mentation was improving to the point where he was able to communicate and open his eyes upon discharge, as well as was working with Physical Therapy for strengthening.  He was able to move his upper extremities and followed commands and lower extremities were improving in strength as well. Patient was discharged via private air flight to acute care ICU facility.
Per mom stated that after the covid Pfizer injection he a fever missed dose on Tuesday.; Per mom stated that after the covid Pfizer injection he a fever missed dose on Tuesday.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. Other Case identifier(s): 20210906000327.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRODUCT DOSE OMISSION ISSUE (non-serious), PYREXIA (non-serious), outcome "unknown" and all described as "Per mom stated that after the covid Pfizer injection he a fever missed dose on Tuesday".  Additional information: Per mom stated that after the Covid Pfizer injection he a fever missed dose on Tuesday.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
injection site red and swollen; has a temperature; The injection site started itching (like a mosquito bite); injection site red and swollen; nausea; vomiting; diarrhea; elevated temperature of 99.3 F; heavy fatigue; This spontaneous case was reported by a consumer and describes the occurrence of   in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J2O-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No specific follow-up information recorded.
318 patients received dose from vials beyond 30 day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30 day use by date) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30 day use by date). On 09-Jun-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30 day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.   This case was linked to MOD-2021-364511 (Patient Link).
patient broke out in sweat and felt nauseated after flu vaccine.  after sitting for awhile with ice pack, pt felt better and was able to leave store
While waiting for 15 mins monitoring after getting Pfizer covid vaccine, she fainted and fell off the chair.  She fell on the ground and hit her head.  Nurse and pharmacy staff rushed to her aid.  She appeared to have convulsions for about a couple seconds but regained conciousness right away.   We checked vital signs : low blood pressure but high heart rate, oxygen level was good.  We placed  ice pack on  her head where said was hurting.   She and her mother refused to call 911.  She felt better, however we recommended her mom to take her to urgent care for further evaluations
This spontaneous report as received from a Licensed Practical Nurse refers to patients of unknown demographics. On an unknown date, an unspecified number of patients received improperly stored PROQUAD (Merck) lot # L005295 (expiry date: 17-AUG-2016) (dose details, lot number unspecified). No adverse effects reported. The outcome was unknown. No product quality complaint was involved. This case is also related to 1507USA001935, 1507USA007761 and 1507USA007759 (same reporter link). Additional information has been requested.
Was fine a/flu shot; got vax in lt deltoid 23OCT91 & on 25OCT91 had pain lt hip to lt ankle (spasm in hip & burning pain along nerve to ankle)-neuralgias; Seen by MD who said cause was flu shot & gave Cortisone shot; pain relief occurred;
injection site was pain  nauseous Appetite lost Day 2 All above plus fatigue extreme Day 3 Uneventful Day 4 Tiredness and above sxs Day 5 Sore throat Hoarseness Weakness Blurry vision Brain fog Unable to work or drive Felt drunk but wasn?t  Positional dizziness Productive cough Pain in lungs Decreased appetite Facial swelling
began coughing 17DEC96 AM;no temp saw MD given ATB sent home several days later still no improvement was taken to different MD-hosp 1JAN97 cont to be hosp 9JAN97;
Pt c/o SOB, Dizziness and lightheaded approx. 5 min after vaccine. Pt was given 50mg oral Benedryl.  Symptoms worsened to feeling of throat tightness.  Rapid Response arrived and took pt to ED
Patient tested positive for covid 12/15/2021.  Contact attempted on 12/22/2021 by health department.  No response.  No charted symptoms or pre-existing conditions listed in reporting system.  Patient died 01/11/2022
Patient was given the 6mo-4yr dose. Provider spoke to the parent regarding the incorrect dose given. Did not re-dose at this visit. Will re-dose at the appropriate interval.
DIZZINESS WHEN STANDING OR MOVING HEAD TOO QUICKLY; FATIGUE (VERY VERY TIRED AND HAS BEEN IN BED MOST OF THE DAY); This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced dizziness when standing or moving head too quickly. On MAR-2021, the subject experienced fatigue (very very tired and has been in bed most of the day). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue (very very tired and has been in bed most of the day) and dizziness when standing or moving head too quickly was not reported. This report was non-serious.
10-16-07: Received vaccination.  10-18-2007:  Woke up and felt aches in legs, arms, and back.  Experienced general malaise and lethargy.  Symptoms were more pronounced upon awakening.  No fever or chills.  Took intermittent ibuprofen 400 mg once to twice daily.  10-27-07:  Symptoms resolved.
feverish; Dizziness; This case was reported by a consumer via call center representative and described the occurrence of fever in a 51-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine at an unknown dose. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced fever and woozy. On an unknown date, the outcome of the fever and woozy were unknown.   It was unknown if the reporter considered the fever and woozy to be related to Shingles vaccine.  Additional details were received as follows: The case was reported by patient's cousin. The age at vaccination was not reported. The reporter stated that the patient felt feverish and woozy after vaccination.
Patient received a Shingrix vaccine on 06/24/2021. Registered nurse administered Shingrix vaccines on 02/08/2023 and 04/10/2023 as the record showed that the Zoster vaccines were "overdue." The registered nursed thought the primary dose was supposed to be restarted since the initial immunization was not completed on schedule.
Developed facial swelling 5/9/1999 @ 23:52. Benadryl IM 12.5, Solu-medrol 20 mg IM given. Pt was directed to Benadryl 125mg/5ml QID x 3 days. Patient told to avoid peanuts, also had peanuts same day.
Moderna COVID-19 Vaccine EUA Fever (102.0 F) - lasted approximately 6 hours Chills - lasted approximately 18 hours Body aches - lasted 2-3 days Nausea, vomiting & diarrhea - lasted approximately 12 hours Severe headache - lasted approximately 24 hours Sore arm - lasted approximately 4 days
Patient was seen in office 05/31/22 for 4 month well child exam. Rotavirus vaccine was given at time of visit, 4 days later (06/04/22) she was seen in ER for intussusception. Symptoms included abdominal pain, vomiting, fussiness. She is now s/p successful reduction of intussusception with barium enema.
Runny nose, sneezing, congestion, exhaustion, lack of appetite, headache for about a week, then serious diarrhea Nov. 24.  Headache and diarrhea eased, but nausea, lack of appetite, exhaustion continued.  Covid text on Nov. 26 negative.
no further AE reported; temperature excursion on Varivax and reported that it was administered to a patient; This spontaneous report was received from a medical assistant and refers to a 1-year-old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 10-SEP-2020, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 ml (reported as 05 milliliter) lot # S038701, expiration date 01-DEC-2021 (route of administration was not provided) for prophylaxis. The vaccine was exposed to -9.6 degrees Celsius for 1 hour 15 minutes. No previous temperature excursions were reported. Digital data logger was involved. No adverse event was reported.
After getting my third shot = booster - I experienced breast pain and lymph node inflammation which hasn?t completely subsided. I have also had irregular periods .
Presented to ED with lower extremity pain that prevented her from walking around the house. Admitted to floor for further work up where X-ray showed potential gout. given steroids and ketorolac. pateint was kept for 2 nights until stable for discharge. Patient had first dose of COVID vaccine followed by a positive COVID test at the hospital 18 days later.
Fever of 102 Body Aches Fluctuating feelings of cold/hot  Sweating Arm pain
This spontaneous report was received from a Medical Assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history or allergy/drug reactions were not reported. On an unknown date, the patient was vaccinated an improperly stored dose of RECOMBIVAX HB (lot # K010535 exp. 27-AUG-206) (dose, route and frequency were unspecified). Concomitant medication was not reported. no adverse event was informed. These was not a product quality complain involved. Additional information has been requested.
pt recv vax OCT96 & devel local rxn which was described as a large, hard, red swelling @ inj site;area was itchy;it was unk whether pt exp was related to vax
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 01-MAY-2013, the patient was vaccinated with a dose of VAQTA, (lot # H019104, expiry date 19-JUL-2015), which was exposed to 31 degree Fahrenheit. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
No symptoms or adverse events occurred. Vaccine was discovered to be non viable d/t temperature excursion and patient will have to be revaccinated. Health department and immunization registry consulted.
Back ache; Stomach ache; Weakness; Sharp chest pain; chest pressure/chest tightness; Chills; Headache / bad headache; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back ache), ABDOMINAL PAIN UPPER (Stomach ache), ASTHENIA (Weakness), CHEST PAIN (Sharp chest pain) and CHEST DISCOMFORT (chest pressure/chest tightness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, the patient experienced HEADACHE (Headache / bad headache). On 07-Aug-2021, the patient experienced BACK PAIN (Back ache), ABDOMINAL PAIN UPPER (Stomach ache), ASTHENIA (Weakness), CHEST PAIN (Sharp chest pain), CHEST DISCOMFORT (chest pressure/chest tightness) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 08-Aug-2021, BACK PAIN (Back ache), ABDOMINAL PAIN UPPER (Stomach ache), ASTHENIA (Weakness), HEADACHE (Headache / bad headache) and CHILLS (Chills) had resolved. At the time of the report, CHEST PAIN (Sharp chest pain) and CHEST DISCOMFORT (chest pressure/chest tightness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow-up contains as reported of chest pressure updated.
Per NYSDOH this is a report of usage of COVID vaccine beyond BUD . Guidanace was to report under the specific lot numbers as opposed to the specific patients. THERE WERE NO REPORTED ADVERSE EVENTS.  GL0446- 26 doses of Pfizer bivalent COVID vaccine were administered to 26 patients beyond the advised beyond use date. The dates of administration were from 1/23/23 through 2/28/2023.  GL2042- 9 doses of Pfizer bivalent COVID vaccine were administered to 9 patients beyond the BUD. The dates of administration were 4/04/23 through 4/24/2023.  GJ5342- 3 doses were administered beyond BUD between 11/22/22 and 2/23/23
42 y/o with moderate persistent asthma on XOLAIR, HTN, SVT, fatty liver, DM, TIA/CVA s/p PFO repair admitted with acute respiratory failure/distress secondary to what appears to be an allergic reaction to influenza shot with severe asthma exacerbation/status, which did not respond to steroids and nebs, requiring initially a BiPAP and then intubation. He was extubated the next day and has been improving since. Post extubation he had episodes of blood in the sputum.
Report A0352431A (formerly 2001021600-1) describes rheumatoid arthritis in a 31 year old female who received Lyme disease vaccine recombinant OspA (LYMErix). This report was received from the vaccinee, who is a pharmacist. The vaccinee had not history of gout, psoriasis, Crohn's disease, or Lyme disease. There was no family history of rheumatoid arthritis or lupus. On 08/18/99 and 09/23/99, the vaccinee received her first and second doses of Lymerix, respectively, without adverse event. In 09/00, she received her 3rd dose of Lymerix. In June 2001, she reportedly began to experience pain in all joints, especially the hips, knees, elbows, and hands. She also experienced stiffness in the knuckles of her fingers. On 07/10/01, she experienced pain in both knee and both elbow joints. The joints were not red or swollen. She was seen by a nurse practitioner in )8/01. No fluids was obtained from any joint. The vaccinee was treated with an unspecified anti-inflammatory medication. Unspecified "lab work" was performed. The vaccinee stated that she was "not sure", but the nurse practitioner called her on 09/07/01 and said she "may have positive lab work for Lyme disease". On 4/10/02, the vaccinee reported that she was seen by a rheumatologist, who made a diagnosis of rheumatoid arthritis of the hands. Reportedly, the symptoms were being treated with celecoxib (Celebrex) 200 mg twice daily and hydroxychloroquine phosphate (Plaquenil) 200 mg twice daily. As of 4/10/02, the rheumatoid arthritis was reportedly ongoing. As of 09/07/01, the outcome of the joint pain was unknown. The adverse event "joint pain" does not meet ICH serious criteria, but is being submitted as an expeditied report by special FDA request per the June 28,2000 letter.
Fever (100.4 degrees), general weakness, headache, strong pain in the place of injection.
I experienced after my J&J vaccine at about 8pm, felt very fatigued with pain at the injection site, felt like drunk feeling which lasted one week. The main thing is that I slept a lot and was unable to work which lasted 9 days. The thing that I went to urgent care for pelvic pain, body aches and pain, developed an UTI and my symptoms cleared at home with medications.  At the urgent care lab work and urine culture was performed. When I went to the urgent care they said I also had tachycardia.  My symptoms have resolved.
Left leg began swelling the next day. Visit to Emergency Room that night. From symptoms and ultrasound of the leg which showed clots and no flow in the femeral vein, diagnosis was deep vein  thrombosis.
Patient was to receive the new bivalent vaccine booster. Due to the original Pfizer vaccine being in a grey top as well it was accidently mistaken for the new bivalent which is also a grey top. 0.3 ml was given. patient does not have any adverse reactions at this time.
I started feeling symptoms on Thursday 1/13, spent the day in bed. Woke up the next day 1/14 and scheduled for testing Friday at 9am. And then results came back at noon on the 1/15/2022 from the clinic app that I was in fact positive.
Vaccinated in Feb/March 2021 and later hospitalized with N17.9 - AKI (acute kidney injury) (CMS/HCC) U07.1 - COVID-19
Starting Sat. Jan. 30 I was dizzy almost every morning when I first sat up on the edge of my bed.  Dizziness stronger sometimes than other.  Dizziness lasted 10 to 20 seconds.  Sometimes when I lie down at night I have this dizziness.  I called specialist office and a man called me back and told me to check blood pressure but I couldn't get blood pressure cuff to work.
Severe arm pain first dose, not able to sleep for 24 hours even with OTC meds Severe arm pain second dose, but able to sleep 3 hrs with OTC meds first night  Arm pain disrupted seep and could not use arm for one week the first time and three days after the second dose  Couldn't eat or drink for 48hrs following each dose. Didn't eat more than one small meal for a day for three months, trouble keeping food down  Periods did not return to normal schedule or bleeding regularly until August 2022  Severe fatigue until May of 2022, unable to stay awake more than three hours a day starting, gradually working up to 12 hours a day awake in May.
pt recv vax; mom said p/ 1st set of vax, pt cried steadily for 4 hr; PC to MD but did not returned call; p/ 4 hr, pt fell asleep & was fine when awoke later;